1. INTRODUCTION
===============

In the United States, between 2010 and 2014 the rate of people living with HIV steadily increased from 275.7/100,000 population to 299.5/100,000 population, respectively. In 2010, the rate of HIV diagnoses was 14.2/100,000 population and the rate declined to 12.3/100,000 population in 2015 \[[@r1]\]. The highest rates of new diagnoses in 2015 were among blacks/African Americans (hereafter referred to as blacks) (44.3/100,000 population), more specifically black males (84.8/100,000 population), blacks aged 20-24 years (111.2/100,000 population) and blacks 25-29 years (112.2/100,000 population) \[[@r1]\]. Hispanics/Latinos also experienced elevated rates of HIV diagnoses over whites although the rates remained at approximately one-third to one-half the rates of blacks with the same sex and age characteristics. The vast majority of males with HIV infection diagnosed in 2015 had infection attributed to male-to-male sexual contact or male-to-male sexual contact in conjunction with injection drug use (86.2%); females had infection attributed primarily to heterosexual contact (86.3%) \[[@r1]\]. For these and other risk groups, prevention services are essential to avoid further spread of HIV infection and, for those living with HIV infection, coordinated supportive services and medical care are crucial \[[@r2]\].

Goals of the National HIV/AIDS strategy for the United States: Updated to 2020 \[[@r3]\] include reducing new HIV infections, increasing access to care and improving health outcomes for people living with HIV infection, reducing HIV-related disparities and health inequities, and achieving a more coordinated national response to the HIV epidemic. Progress toward these goals by 2020 includes: increasing to 85% the number of newly diagnosed persons who are linked to HIV medical care within one month of diagnosis, increasing to 90% the number of persons living with diagnosed HIV who are retained in HIV medical care, increasing to 80% the number of persons diagnosed with HIV who have suppressed viral load, and reducing disparities by focusing on high risk groups comprised of young black gay and bisexual males and black females \[[@r4]\] for whom disparities in HIV diagnoses and treatment outcomes have been demonstrated \[[@r5]-[@r8]\].

Data from the National HIV Surveillance System, described elsewhere \[[@r9], [@r10]\], show that for people with HIV infection diagnosed in 2015 in 37 states and the District of Columbia, 75.0% were linked to care within one month of diagnosis and for those with HIV diagnosed by year-end 2013 and alive at year-end 2014, 72.5% were retained in care and 57.9% had suppressed viral load \[[@r11]\]. All three indicators fall short of national goals. In 2014, for 32 states and the District of Columbia, outcomes for these three indicators were even lower for black males (69.9%, 67.0%, and 47.9% respectively), males aged 18-24 years (66.2%, 71.4%, and 44.4% respectively), and people who inject drugs (74.3%, 64.3%, and 47.1% respectively) \[[@r12]\].

Assessing changes in linkage to care, received care, and viral suppression over the last decade has been hindered by a lack of comprehensive HIV laboratory reporting laws that require reporting of all CD4 results regardless of value and all viral load results including detectable and undetectable; and by incomplete laboratory reporting within states with comprehensive reporting laws \[[@r13]\]. This study examined annual changes for 2012 to 2015 in linkage to care, receipt of care, and viral suppression among adults and adolescents using data reported for 17 jurisdictions to the National HIV Surveillance System. These jurisdictions represented approximately 46% of the U.S. population. We aimed to explore these changes by patient characteristics, stage of HIV infection at diagnosis and transmission category.

2. METHODS
==========

Data reported to the National HIV Surveillance System by December 2016 were used to identify cases of HIV infection that met the CDC HIV infection case definition \[[@r14]\] among persons aged 13 years and older at time of diagnosis and whose residence at diagnosis (for linkage to care) and most current residence (for receipt of care and viral suppression) were within one of 17 identified jurisdictions with complete laboratory reporting. To be eligible for inclusion jurisdictions were required to meet the following three criteria for each year between 2012 and 2015:

-   The jurisdiction's laws/regulations required the reporting of all CD4 and viral load results to the state/city health department,

-   Laboratories that perform HIV-related testing for the areas must have reported a minimum of 95% of HIV-related test results to the state/city health department, and

-   By December 31, 2016, the area had reported to CDC at least 95% of all CD4 and viral load test results received from January 2012 through December 2015.

The jurisdictions that met inclusion criteria were California, District of Columbia, Hawaii, Iowa, Illinois, Indiana, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, North Dakota, South Carolina, Texas, Utah, and West Virginia.

Linkage-to-care analysis included people with HIV infection diagnosed between January 1^st^ and December 31^st^ of the outcome year (*e.g.*, the outcome for 2012 includes all diagnoses between January 1, 2012 and December 31, 2012). Linkage to care was defined as ≥1 CD4 or viral load test performed within 1 month of diagnosis.

Receipt of care and viral load suppression analyses included people with HIV diagnosed before January 1^st^ of the outcome year and not known to be deceased on December 31^st^ of the outcome year (*e.g.*, the result for 2012 includes all persons with an HIV diagnosis before January 1, 2012 and not known to be deceased on December 31, 2012). Receipt of care was defined as ≥1 CD4 or viral load test performed during the outcome year. Viral suppression was defined as a viral load result of \<200 copies/mL or, if the quantitative value was missing, a test interpretation value of "undetected", at the time of the most recent viral load test during the outcome year.

Laboratory results with missing month or year of specimen collection were excluded from the analysis (\<0.36% for linkage-to-care and \<0.16% for receipt of care and viral suppression). All duration times were calculated using the month and year for both HIV infection diagnosis and laboratory results. If a patient had two tests in the same month with different viral suppression results, we applied a conservative approach and used the test result that indicated a higher viral load. In addition, laboratory tests with a missing result and tests with specimen collection dates prior to the date of HIV infection diagnosis were excluded.

The twelve-month interval between the last observation year (2015) and dataset used (reporting through December 2016) allowed time for reporting of diagnoses, laboratory results, and deaths. Data were adjusted for unknown or missing transmission category \[[@r15]\]. Results are presented by age group (13-24, 25-34, 35-44, 45-54, ≥55), sex, race/ethnicity (black, Hispanic/Latino, white, and other) (those with missing race/ethnicity were excluded from the analysis), and transmission category (male-to-male sexual contact, people who inject drugs, male-to-male sexual contact and injection drug use, heterosexual contact, and other). Stage of disease at diagnosis was categorized as diagnosis of HIV-infection Stage 3 \[AIDS\] within 3 months of an HIV diagnosis, or the absence of HIV-infection Stage 3 \[AIDS\] diagnosis within 3 months of an HIV diagnosis. The estimated annual percent change (EAPC) was calculated for each person characteristic and considered statistically significant at *P*-value \<.05. All analyses were conducted using SAS 9.3 (SAS Institute, Inc., Cary, NC). This project was approved by CDC as a retrospective, secondary data analysis using HIV surveillance data. This analysis did not constitute research involving identifiable human subjects requiring IRB review.

3. RESULTS
==========

Linkage to care among the 81,174 (2012=20,876; 2013=19,887; 2014=20,467; and 2015=19,944) people with HIV infection diagnosed between January 1, 2012 and December 31, 2015 increased each year from 2012-2015 (79.9%, 81.4%, 82.9%, and 83.7% respectively, EAPC = 1.6, 95% CI 0.9-2.3, *P*\<.001) (Table **[1](#T1){ref-type="table"}**). In 2015, linkage to care was higher among whites compared with all other races/ethnicities, older age groups compared with younger age groups, and those with HIV-infection Stage 3 \[AIDS\] compared with those without stage 3 \[AIDS\] diagnosis. Linkage was also higher among women and those with infection attributed to heterosexual contact. Linkage to care increased significantly from 2012-2015 among males (EAPC=1.6, 95% CI 0.9-2.4, *P*\<.001), blacks (EAPC=2.2, 95% CI 1.1-3.3, *P\<*.001), those with HIV diagnosed earlier than stage 3 (AIDS) (EAPC=2.4, 95% CI 1.6-3.2, *P*\<.001), males with infection attributed to male-to-male sexual contact (EAPC=1.6, 95% CI 0.7-2.4, *P*\<.001), those aged 13-24, 25-34, and 35-44 years at diagnosis (EAPC=3.2, 95% CI 1.7-4.7, *P*\<.001, EAPC=1.3, 95% CI 0.1-2.5, *P*=.039, and EAPC=1.7, 95% CI 0.2-3.2, *P*=.031 respectively), and those with a transmission category of heterosexual contact (EAPC=1.8, 95% CI 0.4-3.3, *P*=.014).

By race/ethnicity and sex, linkage to care increased among black males overall (EAPC=2.5, 95% CI 1.2-3.8, *P*\<0.001), and specifically among black males aged 13-24 years (EAPC=3.4, 95% CI 1.1-5.8, *P*=0.004), those in earlier than stage 3 of the disease at diagnosis (EAPC=3.8, 95% CI 2.2-5.3, *P*\<0.001) and those with infection attributed to male-to-male sexual contact (EAPC=2.4, 95% CI 1.0-3.9, *P*=0.001) (Table **[2](#T2){ref-type="table"}**). Black females showed no significant improvements in linkage to care from 2012-2015 with the exception of those with HIV-infection diagnosed without stage 3 \[AIDS\] (*P=*0.045). Similarly, linkage to care among Hispanic/Latino males aged 13-24 years (EAPC=3.2, 95% CI 0.3-6.2, *P*=0.033) and those with HIV infection without a diagnosis of stage 3 \[AIDS\] (EAPC=2.1, 95% CI 0.5-3.8, *P*=0.010) increased. There were no significant increases in linkage to care from 2012-2015 among Hispanic/Latino females or white males or females.

Overall, the proportion of people with diagnosed HIV infection who received care increased from 2012 to 2015 (EAPC=0.6, 95% CI 0.4-0.8, *P*\<0.001) (Table **[3](#T3){ref-type="table"}**). Receipt of care increased significantly for all individual categories of person characteristics assessed from 2012 to 2015, with the exception of those identifying as other race/ethnicity and other transmission category, those aged 45-54 years, and people who inject drugs. In each of the four years, the proportion of people who received care was consistently higher among whites and those classified as other race/ethnicity compared to blacks and Hispanics/Latinos and consistently lowest among those with a transmission category of injection drug use. There was little variation among age groups within years.

By race/ethnicity and sex, significant increases in the proportion of those who received care annually from 2012-2015 were found among black males of all ages except ≤55 years, Hispanic/Latino males aged 13-24 and 25-34 years, and all racial/ethnic groups diagnosed without Stage 3 \[AIDS\] except Hispanic/Latino and white females (Table **[4](#T4){ref-type="table"}**). Receipt of care increased from 2012-2015 among all racial/ethnic groups of men who have male to male sexual contact (blacks EAPC=1.0, 95% CI 0.6-1.4, *P*\<.001; Hispanics/Latinos EAPC=0.8, 95% CI 0.4-1.2, *P*\<.001; whites EAPC=0.5, 95% CI 0.1-0.8, *P*=.004). Receipt of care also increased among black females aged 35-44 years (EAPC=1.0, 95% CI 0.2-1.8, *P=*.020) and transmission category of heterosexual contact (EAPC=0.7, 95% CI 0.2-1.2, *P=*.008).

Viral suppression among people with diagnosed HIV infection increased annually from 2012 to 2015 overall (53.4%, 56.4%, 58.8%, and 59.2% respectively) (EAPC=3.5, 95% CI 3.3-3.7, *P*\<.001) (Table **[5](#T5){ref-type="table"}**) and for all categories of person characteristics assessed. Within years, the proportion of people achieving viral suppression was consistently greater among males, whites, and people with HIV infection Stage 3 \[AIDS\], and consistently lowest among those with a transmission category of injection drug use. The proportion of those achieving viral suppression increased with age each year.

By race/ethnicity and sex, viral suppression increased annually from 2012-2015 for all characteristics except transmission category of other for all racial/ethnic groups, and Hispanic/Latino and white females aged 13-24 years (Table **[6](#T6){ref-type="table"}**).

4. DISCUSSION/IMPLICATIONS
==========================

This analysis explored progress in linkage to care, receipt of care, and viral suppression among people with HIV infection for outcome years 2012-2015 in 17 U.S. jurisdictions meeting the criteria for complete laboratory reporting for each of the four years. Linkage-to-care increases were found among some high-risk populations, particularly young people, blacks, males, and those engaging in male-to-male sexual contact. However, an increase was found in only one category of black women, those with a diagnosis of HIV Stage 3 \[AIDS\], despite black women being a priority population for HIV prevention. Notably, Hispanic/Latino and white females and white males showed no improvement in linkage to care from 2012-2015; however, the proportions at which they were linked to care were close to or higher than the national standard and exceeded linkage for black males by approximately five percentage points.

Generally, receipt of care improved among the same populations as linkage to care and also showed improvements for white men who have male to male sexual contact. Once again, no improvements were found among Hispanic/Latino or white women. Despite limited improvement in linkage to and receipt of care, and similar to another study \[[@r16]\], increases in viral suppression were seen in nearly every category of person characteristics assessed. This is potentially due to a number of factors including improvements in linkage to care and receipt of care that were found and increased prescribing of or compliance with antiretroviral therapy.

The distinction in linkage to and receipt of care and viral suppression between those with HIV diagnosed at stage 3 \[AIDS\] and not at stage 3 \[AIDS\] is prominent. Those with stage 3 \[AIDS\] are linked to care in greater proportions than those not in stage 3 \[AIDS\]. However, the differences between the two groups disappear for receipt of care. Then, once again, those with HIV diagnosed at Stage 3 \[AIDS\] achieve viral suppression more often than those not at stage 3 \[AIDS\]. These variations suggest the need to better understand why those with stage 3 \[AIDS\] are linked but did not receive care in any greater proportion than those not at stage 3 \[AIDS\].

A similar scenario is seen for linkage to and receipt of care and viral suppression by age group. While linkage to care and viral suppression both increase as age increases, this is not the case for receipt of care where the proportions vary within age categories. A better understanding of the impact of age on receipt of care could be important in increasing the proportion of those virally suppressed for all age groups.

Studies documenting the impact of poverty, poor education, substance use, mental health challenges, domestic violence, transportation to medical care, and lack of social support and employment on HIV care and treatment are abundant, and demonstrate disproportional impact on black men and women and Hispanics/Latinos, and on high-risk populations such as people who inject drugs and young men having sexual contact with men \[[@r7], [@r17]-[@r23]\]. Despite these barriers a number of evidence-based programs targeting these populations, including pre-exposure prophylaxis, demonstrate effective outcomes \[[@r24]-[@r26]\]. However, within years substantial differences remain in linkage to and receipt of care and viral suppression with whites exceeding blacks and Hispanics/Latinos, suggesting the effectiveness of programs to reduce the health disparities are limited \[[@r27]\].

The analysis was subject to several limitations. First, the outcomes assessed included only cases identified through 2015 and were under the guidance of the National HIV/AIDS Strategy for the United States: July 2010 \[[@r28]\]. The 2010 guidance established a linkage to care goal of 65% which was met for virtually every person characteristic group assessed and a retention in care goal of 80% for which our more liberal definition showed no person characteristic group met the goal. The 2010 guidance also set a goal of a 20% increase in the proportion of HIV diagnosed gay and bisexual men as well as Blacks with undetectable viral load which we cannot assess as we used 2012-2015 data. Improvements in testing and care and treatment since 2015 make it critical to continue to assess these outcomes under the new 2020 strategy released in July 2015. Second, the 17 jurisdictions may not be representative of all people with HIV infection in the United States. To mitigate the lack of representation we looked back no further than 2012. Including earlier years would have further reduced the number of states eligible for the analysis. Third, the EAPC for linkage to care is based on only four years of data due to the lack of complete laboratory reporting in other jurisdictions. Fourth, documentation of the most recent viral load may not be indicative of consistent viral suppression in this population over time \[[@r29]\] and further studies are needed to understand factors contributing to long term viral suppression. Fifth, exclusion of laboratory results with missing month or year of specimen collection date may underestimate linkage-to-care, receipt-of-care, and viral suppression. To address the majority of the limitation above, states continue to work with their legislatures to enact mandatory HIV-related laboratory test result reporting laws and all but six (Idaho, Kansas, New Jersey, Pennsylvania, Vermont, and the Virgin Islands) have now done so with the latest being Arizona in 2018. Opportunities to expand analyses will occur as states collect this data. Additional studies are needed as more jurisdictions begin to meet the laboratory reporting requirements.

CONCLUSION
==========

Improving care and treatment for people with HIV infection and reducing HIV-related disparities across the three indicators studied show some promising results; however, linkage-to-care and viral suppression indicators fall short of National HIV/AIDS Strategy for the United States: Updated to 2020 goals. While not a national indicator, the more inclusive definition used in this study for receipt of care (one HIV-related medical visit per year) still falls short of the retention in care (two or more HIV-related medical visits more than three months apart in a year) national goal and thus there also remain opportunities for improvement in receipt of care.

Prevention programs that are scientifically proven, cost-effective, scalable and targeted to high-risk populations are the foundation for stopping transmission of HIV infection. Frequent testing to support early diagnosis and prompt linkage to medical care, particularly among young men who have male to male sexual contact and black and Hispanic/Latino populations, are key to reducing transmission at all stages of disease, and specifically among those with acute infection when transmission risk is high. The substantial disparity in receipt of care and viral suppression among racial/ethnic groups suggests the need for improved targeting of interventions based on social determinants of health. Resources are still needed to monitor and improve outcomes across the HIV continuum of care. The transition from the July 2010 national strategy to the 2020 updated national strategy presents an opportunity to reassess local, state, and national programs to reach these care continuum goals.
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Linkage to care among persons aged ≥13 years with HIV diagnosed during 2012-2015, by selected characteristics \-- 17 US jurisdictionsa

  **Characteristic**                                         **Total**    **Linked to care^b^ for persons diagnosed in the year**              **Trends from 2012 - 2015**                                                                                            
  ---------------------------------------------------------- ------------ --------------------------------------------------------- ---------- ----------------------------- ---------- ------------ ---------- ------------ ---------- --------- --------- --------- ------------
  **Sex**                                                                                                                                                                                                                                                              
        Male                                                 66,312       13,464                                                    79.6       13,150                        81.0       13,822       82.5       13,693       83.5       1.6       0.9       2.4       \<.001
        Female                                               14,862       3,206                                                     81.1       3,047                         83.3       3,137        84.5       3,002        84.8       1.5       -0.1      3.1       0.068
  **Race/Ethnicity**                                                                                                                                                                                                                                                   
        Black/African American                               33,116       6,499                                                     75.8       6,398                         78.2       6,686        80.5       6,506        80.8       2.2       1.1       3.3       \<.001
        Hispanic/Latino                                      22,751       4,577                                                     80.1       4,511                         82.6       4,807        82.5       4,802        83.6       1.3       0.0       2.6       0.055
        White                                                19,825       4,408                                                     85.7       4,154                         85.7       4,285        86.3       4,280        87.9       0.8       -0.5      2.2       0.228
        Other                                                5,482        1,186                                                     81.9       1,134                         81.6       1,181        86.3       1,107        86.7       2.3       -0.3      5.0       0.087
  **Age group at diagnosis**                                                                                                                                                                                                                                           
        13-24                                                18,434       3,504                                                     74.3       3,484                         77.8       3,711        78.4       3,710        82.3       3.2       1.7       4.7       \<.001
        25-34                                                26,026       5,056                                                     79.4       5,012                         80.2       5,474        82.4       5,556        82.2       1.3       0.1       2.5       0.039
        35-44                                                16,418       3,510                                                     80.7       3,371                         83.7       3,525        84.5       3,286        84.9       1.7       0.2       3.2       0.031
        45-54                                                13,057       3,045                                                     84.3       2,759                         84.7       2,683        86.1       2,642        86.1       0.8       -0.9      2.5       0.345
        55+                                                  7,239        1,555                                                     84.9       1,571                         83.8       1,566        87.0       1,501        86.6       1         -1.3      3.2       0.406
  **Stage at diagnosis**                                                                                                                                                                                                                                               
        HIV infection stage 3(AIDS)                          18,072       4,805                                                     98.6       4,471                         98.8       4,429        99.1       4,177        99.4       0.3       -1.0      1.6       0.693
        Not known to be HIV infection stage 3                63,102       11,865                                                    74.1       11,726                        76.3       12,530       78.3       12,518       79.5       2.4       1.6       3.2       \<.001
  **Transmission Category^c^**                                                                                                                                                                                                                                         
        Male-to-male sexual contact                          55,276       11,138                                                    79.7       10,904                        81.2       11,677       82.7       11,490       83.5       1.6       0.7       2.4       \<.001
        Injection drug use                                   5,010        1,054                                                     77.4       934                           77.2       904          79.9       1,046        80.1       1.3       -1.4      4.1       0.341
        Male-to-male sexual contact and injection drug Use   2,646        596                                                       81.1       533                           79.4       530          82.2       504          84.7       1.6       -2.2      5.5       0.422
        Heterosexual contact**^d^**                          18,068       3,842                                                     80.7       3,787                         83.4       3,821        84.5       3,622        85.3       1.8       0.4       3.3       0.014
        Other**^e^**                                         174          40                                                        78.5       39                            83.9       27           69.0       33           84.8       0.5       -13.4     16.5      0.952
  **Total**                                                  **81,174**   **16,670**                                                **79.9**   **16,197**                    **81.4**   **16,959**   **82.9**   **16,695**   **83.7**   **1.6**   **0.9**   **2.3**   **\<.001**

Abbreviations: HIV= Human Immunodeficiency Virus, EAPC=Estimated Annual Percent Change. Note: The denominator for each characteristic for each year are not presented. ^a^Jurisdictions include California, District of Columbia, Hawaii, Iowa, Illinois, Indiana, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, North Dakota, South Carolina, Texas, Utah, and West Virginia. ^b^Defined as one or more CD4+ T-lymphocyte or viral load test within 1 month after HIV diagnosis. ^c^Data statistically adjusted to account for missing transmission categories. ^d^Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. ^e^Includes hemophilia, blood transfusion, perinatal exposure and risk factor not reported or not identified.

###### 

Linkage to care among persons aged ≥13 years with HIV diagnosed during 2012-2015, by race, sex and selected characteristics -- 17 US jurisdictionsa.

  **Characteristic**                                         **Total**    **Linked to care^b^ for persons diagnosed in the year**   **Trends from 2012 - 2015**                                                                                                         
  ---------------------------------------------------------- ------------ --------------------------------------------------------- ----------------------------- ------------ ---------- ------------ ---------- ------------ ---------- --------- --------- --------- ------------
  **Black Males**                                                                                                                                                                                                                                                        
        **Age group at diagnosis**                                                                                                                                                                                                                                       
        13-24                                                8,002        1,442                                                     70.5                          1,482        74.7       1,541        75.0       1,511        78.8       3.4       1.1       5.8       0.004
        25-34                                                7,513        1,242                                                     73.5                          1,356        75.4       1,591        80.4       1,594        77.9       2.3       0.0       4.7       0.054
        35-44                                                3,612        747                                                       75.9                          705          78.4       721          82.2       683          80.2       2.2       -1.1      5.5       0.198
        45-54                                                3,090        692                                                       76.8                          631          79.4       571          82         569          81.5       2.2       -1.3      5.8       0.227
        55+                                                  1,890        384                                                       79.7                          374          78.2       404          82.6       364          82.5       1.6       -2.9      6.3       0.485
        **Stage at diagnosis**                                                                                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          4,808        1,304                                                     98.4                          1,171        99.3       1,208        99.5       1,085        99.5       0.4       -2.1      3.0       0.774
        Not known to be HIV infection stage 3                19,299       3,203                                                     67.1                          3,377        70.7       3,620        74.1       3,636        74.8       3.8       2.2       5.3       \<.001
        **Transmission Category^c^**                                                                                                                                                                                                                                     
        Male-to-male sexual contact                          19,012       3,463                                                     73.9                          3,562        76.7       3,876        79.1       3,790        79.3       2.4       1.0       3.9       0.001
        Injection drug use                                   1,212        284                                                       75.2                          216          72.2       204          76.6       202          75.4       0.6       -5        6.5       0.841
        Male-to-male sexual contact and injection drug use   603          102                                                       69.0                          116          67.3       124          79.5       95           75.6       4.8       -3.9      14.3      0.292
        Heterosexual contact**^d^**                          3,229        647                                                       74.1                          644          77.9       615          81.0       625          81.1       3.1       -0.4      6.8       0.08
        Other**^e^**                                         51           11                                                        65.6                          10           89.2       9            72.5       8            72.2       1.6       -23       34.1      0.911
        **Subtotal**                                         24,107       4,507                                                     73.9                          4,548        76.4       4,828        79.2       4,721        79.3       2.5       1.2       3.8       \<.001
  **Black Females**                                                                                                                                                                                                                                                      
        **Age group at diagnosis**                                                                                                                                                                                                                                       
        13-24                                                1,479        311                                                       76.4                          307          80.4       279          79.9       286          83.9       2.8       -2.3      8.1       0.289
        25-34                                                2,364        512                                                       80.8                          470          82.6       493          84         480          83.6       1.2       -2.7      5.3       0.541
        35-44                                                2,111        448                                                       79.3                          441          83.8       455          84.1       400          83.5       1.7       -2.5      6.0       0.446
        45-54                                                1,827        458                                                       84.0                          384          84.2       357          85.0       355          87.4       1.3       -3.1      5.8       0.6
        55+                                                  1,228        263                                                       81.9                          248          82.9       274          89.0       264          88.0       2.9       -2.5      8.6       0.302
        **Stage at diagnosis**                                                                                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          2,092        573                                                       99.1                          501          98.8       529          99.2       472          99.6       0.2       -3.6      4.1       0.932
        Not known to be HIV infection stage 3                6,917        1,419                                                     74.9                          1,349        78.2       1,329        79.5       1,313        80.8       2.5       0.1       4.9       0.045
        **Transmission Category^c^**                                                                                                                                                                                                                                     
        Injection drug use                                   948          236                                                       76.8                          184          80.0       165          78.3       161          80.2       1.2       -5.0      7.8       0.715
        Heterosexual contact**^d^**                          8,017        1,746                                                     81.1                          1,653        83.2       1,689        85         1,615        85.5       1.8       -0.3      4         0.097
        Other**^e^**                                         43           10                                                        89.4                          13           88.6       4            54.2       9            93.1       -2.1      -27.1     31.4      0.887
        **Subtotal**                                         9,009        1,992                                                     80.6                          1,850        82.9       1,858        84.3       1,785        85.0       1.8       -0.2      3.9       0.083
  **Hispanic/Latino Males**                                                                                                                                                                                                                                              
        **Age group at diagnosis**                                                                                                                                                                                                                                       
        13-24                                                4,586        864                                                       75.0                          848          79.8       940          79.5       992          83.4       3.2       0.3       6.2       0.033
        25-34                                                7,532        1,507                                                     80.1                          1,497        80.5       1,568        81.9       1,555        82.8       1.2       -1.1      3.5       0.301
        35-44                                                4,334        860                                                       80.2                          879          86.0       942          82.8       930          84.3       1.1       -1.8      4.1       0.459
        45-54                                                2,519        550                                                       84.6                          512          85.3       529          85.6       547          84.0       -0.2      -3.8      3.6       0.925
        55+                                                  996          217                                                       87.1                          203          85.3       208          86.7       227          84.4       -0.8      -6.5      5.2       0.784
        **Stage at diagnosis**                                                                                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          4,667        1,201                                                     98.4                          1,171        99.0       1,129        98.8       1,110        99.0       0.2       -2.4      2.8       0.906
        Not known to be HIV infection stage 3                15,300       2,797                                                     73.9                          2,768        76.9       3,058        77.5       3,141        79.1       2.1       0.5       3.8       0.01
        **Transmission Category^c^**                                                                                                                                                                                                                                     
        Male-to-male sexual contact                          17,246       3,398                                                     79.5                          3,348        82.1       3,644        82.1       3,721        83.4       1.4       0.0       2.9       0.056
        Injection drug use                                   782          175                                                       77.7                          153          81.3       145          81.0       145          76.6       -0.3      -7.0      6.8       0.924
  Male-to-male sexual contact and injection drug use         743          178                                                       83.7                          144          79.2       145          81.6       145          84.5       0.4       -6.4      7.7       0.903
        Heterosexual contact**^d^**                          1,175        244                                                       84.3                          290          88.2       250          85.5       235          88.8       1.2       -4.3      7.1       0.671
        Other**^e^**                                         21           3                                                         63.0                          4            84.8       4            83.0       5            91.4       11.2      -27.0     69.1      0.622
        **Subtotal**                                         19,967       3,998                                                     79.9                          3,939        82.4       4,187        82.2       4,251        83.5       1.3       -0.1      2.7       0.059
  **Hispanic/Latino Females**                                                                                                                                                                                                                                            
        **Age group at diagnosis**                                                                                                                                                                                                                                       
        13-24                                                465          88                                                        75.2                          86           81.1       111          83.5       87           79.8       2.2       -6.8      12.0      0.646
        25-34                                                729          147                                                       76.6                          134          78.4       149          77.6       136          78.2       0.5       -6.6      8.2       0.886
        35-44                                                674          149                                                       87.1                          147          86.0       153          86.4       133          85.8       -0.4      -7.5      7.2       0.914
        45-54                                                550          115                                                       85.8                          129          87.8       112          82.4       120          90.2       0.9       -7.0      9.4       0.834
        55+                                                  366          80                                                        84.2                          76           88.4       95           95.0       75           88.2       2.3       -7.2      12.8      0.649
        **Stage at diagnosis**                                                                                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          699          175                                                       97.8                          174          98.3       177          98.9       164          100.0      0.7       -5.8      7.7       0.831
        Not known to be HIV infection stage 3                2,085        404                                                       76.2                          398          79.0       443          79.2       387          78.7       1         -3.3      5.5       0.654
        **Transmission Category^c^**                                                                                                                                                                                                                                     
        Injection drug use                                   370          69                                                        74.8                          74           74.8       77           80.1       66           79.7       2.7       -7.7      14.2      0.623
        Heterosexual contact**^d^**                          2,408        508                                                       82.7                          497          85.5       542          84.6       484          84.7       0.6       -3.3      4.6       0.762
        Other**^e^**                                         7            2                                                         85.0                          2            90.0       1            100.0      1            63.6       -4.3      -56.2     109.3     0.912
        **Subtotal**                                         2,784        579                                                       81.7                          572          84.0       620          84.0       551          84.0       0.9       -2.8      4.6       0.646
  **White Males**                                                                                                                                                                                                                                                        
        **Age group at diagnosis**                                                                                                                                                                                                                                       
        13-24                                                2,444        483                                                       81.6                          494          84.2       548          83.3       538          88.6       2.4       -1.5      6.5       0.23
        25-34                                                5,364        1,134                                                     84.6                          1,060        84.6       1,132        84.1       1,222        85.8       0.4       -2.2      3.0       0.789
        35-44                                                3,896        916                                                       85.1                          831          86.6       859          87.7       799          90.8       2.1       -1.0      5.2       0.184
        45-54                                                3,832        977                                                       89.7                          834          87.9       823          88.8       778          89.7       0.1       -2.9      3.1       0.972
        55+                                                  2,073        448                                                       90.0                          505          86.9       461          89.7       432          90.0       0.4       -3.7      4.6       0.867
        **Stage at diagnosis**                                                                                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          4,008        1,046                                                     98.8                          1,020        98.5       961          98.9       934          99.3       0.2       -2.6      3.0       0.898
        Not known to be HIV infection stage 3                13,601       2,912                                                     82.4                          2,704        82.1       2,862        82.9       2,835        85.4       1.2       -0.5      2.9       0.156
        **Transmission Category^c^**                                                                                                                                                                                                                                     
        Male-to-male sexual contact                          15,056       3,428                                                     86.3                          3,197        86.2       3,305        86.7       3,159        88.6       0.8       -0.7      2.4       0.281
        Injection drug use                                   775          119                                                       83.0                          134          80.4       157          83.5       231          83.5       0.6       -6.1      7.8       0.859
        Male-to-male sexual contact and injection drug use   1,109        262                                                       85.4                          244          87.9       224          84.7       230          88.3       0.6       -4.9      6.4       0.828
        Heterosexual contact**^d^**                          639          140                                                       85.8                          143          85.0       133          86.2       144          94.7       3.2       -4.2      11.2      0.406
        Other**^e^**                                         30           9                                                         93.8                          6            79.0       4            58.6       5            96.1       -4.6      -34.0     37.8      0.802
        **Subtotal**                                         17,609       3,958                                                     86.1                          3,724        86         3,823        86.4       3,769        88.5       0.8       -0.6      2.3       0.242
  **White Females**                                                                                                                                                                                                                                                      
        **Age group at diagnosis**                                                                                                                                                                                                                                       
        13-24                                                277          62                                                        77.5                          42           73.7       64           86.5       60           90.9       6.4       -5.1      19.2      0.289
        25-34                                                623          123                                                       81.5                          108          84.4       134          81.7       145          80.6       -0.7      -7.9      7.2       0.866
        35-44                                                555          110                                                       79.1                          113          81.3       102          81.6       125          82.2       1.2       -6.7      9.7       0.776
        45-54                                                473          92                                                        88.5                          99           86.8       108          90.0       118          87.4       0         -8.3      8.9       0.995
        55+                                                  288          63                                                        87.5                          68           84.0       54           90.0       63           84.0       -0.6      -11.0     11.0      0.918
        **Stage at diagnosis**                                                                                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          509          156                                                       98.7                          121          98.4       112          100.0      116          100.0      0.5       -6.9      8.5       0.893
        Not known to be HIV infection stage 3                1,707        294                                                       75.8                          309          78.0       350          81.2       395          80.3       2.1       -2.7      7         0.398
        **Transmission Category^c^**                                                                                                                                                                                                                                     
        Injection drug use                                   644          109                                                       77.4                          114          79.0       102          80.9       187          80.7       1.4       -5.9      9.2       0.715
        Heterosexual contact**^d^**                          1,560        338                                                       84.2                          315          84.6       358          86.4       322          86.2       0.9       -3.8      5.9       0.704
        Other**^e^**                                         12           3                                                         79.5                          1            46.2       2            75.0       2            66.7       -3.2      -47.5     78.6      0.918
        **Subtotal**                                         2,216        450                                                       82.4                          430          82.9       462          85.1       511          84.0       0.8       -3.1      5.0       0.687
  **Total**                                                  **81,174**   **16,670**                                                **79.9**                      **16,197**   **81.4**   **16,959**   **82.9**   **16,695**   **83.7**   **1.6**   **0.9**   **2.3**   **\<.001**

Abbreviations: HIV= Human Immunodeficiency Virus, EAPC=Estimated Annual Percent. Note: The denominator for each characteristic for each year are not presented. ^a^Jurisdictions include California, District of Columbia, Hawaii, Iowa, Illinois, Indiana, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, North Dakota, South Carolina, Texas, Utah, and West Virginia. ^b^Defined as one or more CD4+ T-lymphocyte or viral load test within 1 month after HIV diagnosis. ^c^Data statistically adjusted to account for missing transmission categories. ^d^Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. ^e^Includes hemophilia, blood transfusion, perinatal exposure and risk factor not reported or not identified.

###### 

Receipt of care among persons aged ≥13 years living with HIV, 17 US jurisdictions^a^, 2012-2015.

  **Characteristic**                                         **Receipt of Care^b^**                                                                                                                       
  ---------------------------------------------------------- ------------------------ ---------- ------------- ---------- ------------- ---------- ------------- ---------- --------- --------- --------- ------------
  **Sex**                                                                                                                                                                                                 
        Male                                                 240,338                  70.8       250,253       71.6       261,047       72.5       267,644       72.1       0.7       0.5       0.8       \<.001
        Female                                               72,100                   71.5       73,956        72.2       75,582        72.4       77,191        72.4       0.4       0.1       0.7       .011
  **Race/Ethnicity**                                                                                                                                                                                      
        Black/African American                               117,215                  68.2       122,090       69.4       126,963       69.9       130,784       69.8       0.8       0.5       1.1       \<.001
        Hispanic/Latino                                      75,236                   68.9       78,513        69.3       82,354        70.2       85,046        69.8       0.5       0.2       0.8       \<.001
        White                                                98,207                   74.7       101,076       75.3       103,959       76.4       105,162       75.7       0.5       0.3       0.8       \<.001
        Other                                                21,780                   78.8       22,530        79.4       23,353        79.7       23,843        79.4       0.3       -0.3      0.8       .379
  **Age group at diagnosis**                                                                                                                                                                              
        13-24                                                10,941                   70.2       11,546        72.5       11,819        74.5       11,753        75.2       2.4       1.5       3.2       \<.001
        25-34                                                42,941                   68.9       45,144        70.4       48,086        71.8       50,639        72.5       1.7       1.3       2.1       \<.001
        35-44                                                76,771                   70.2       74,827        71.0       73,406        71.6       71,621        71.4       0.6       0.3       0.9       \<.001
        45-54                                                114,184                  72.7       116,821       73.3       118,737       73.8       118,052       73.2       0.2       0         0.5       .058
        55+                                                  67,601                   70.3       75,871        70.8       84,581        71.5       92,770        71.0       0.3       0         0.6       .039
  **Stage at diagnosis**                                                                                                                                                                                  
        HIV infection stage 3(AIDS)                          77,369                   70.8       79,592        71.5       81,523        72.0       82,732        71.7       0.4       0.1       0.7       .006
        Not known to be HIV infection stage 3                235,069                  71.0       244,617       71.8       255,106       72.6       262,103       72.3       0.6       0.5       0.8       \<.001
  **Transmission Category^c^**                                                                                                                                                                            
        Male-to-male sexual contact                          172,781                  72.7       181,665       73.4       191,919       74.4       198,957       73.9       0.6       0.4       0.8       \<.001
        Injection drug use                                   44,880                   63.9       44,843        64.6       44,350        64.6       43,421        63.9       0         -0.4      0.4       .926
        Male-to-male sexual contact and injection drug use   21,469                   75.3       21,684        76.5       21,828        77.2       21,607        76.6       0.6       0         1.2       .037
        Heterosexual contact**^d^**                          72,026                   70.6       74,735        71.4       77,251        71.7       79,574        71.8       0.5       0.2       0.8       .001
        Other**^e^**                                         1,282                    68.8       1,283         69.4       1,281         69.8       1,276         69.0       0.1       -2.3      2.6       .912
  **Total**                                                  **312,438**              **70.9**   **324,209**   **71.7**   **336,629**   **72.5**   **344,835**   **72.2**   **0.6**   **0.4**   **0.8**   **\<.001**

Abbreviations: HIV= Human Immunodeficiency Virus, EAPC=Estimated Annual Percent Change. Note: The denominator for each characteristic for each year are not presented. ^a^Jurisdictions include California, District of Columbia, Hawaii, Iowa, Illinois, Indiana, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, North Dakota, South Carolina, Texas, Utah, and West Virginia. ^b^Defined as one or more CD4+ T-lymphocyte or viral load test performed during the outcome year. ^c^Data statistically adjusted to account for missing transmission categories. ^d^Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. ^e^Includes hemophilia, blood transfusion, perinatal exposure and risk factor not reported or not identified.

###### 

Receipt of care among persons aged ≥13 years living with HIV in 17 US jurisdictions^a^ by race, sex and selected characteristics, 2012-2015

  **Characteristic**                                         **Receipt of Care^b^**                                                                                                                       
  ---------------------------------------------------------- ------------------------ ---------- ------------- ---------- ------------- ---------- ------------- ---------- --------- --------- --------- ------------
  **Black Male**                                                                                                                                                                                          
        **Age group at diagnosis**                                                                                                                                                                        
        13-24                                                4,694                    68.3       5,059         70.8       5,269         73.0       5,216         73.4       2.5       1.2       3.7       \<.001
        25-34                                                12,119                   66.5       13,252        68.5       14,932        70.4       16,586        71.3       2.3       1.6       3.1       \<.001
        35-44                                                16,430                   66.9       16,071        68.4       15,972        69.4       15,772        69.5       1.3       0.6       2.0       \<.001
        45-54                                                26,489                   68.4       27,001        70.0       27,228        70.3       26,736        69.8       0.6       0.1       1.2       .018
        55+                                                  16,234                   64.6       18,275        65.2       20,111        65.3       21,898        64.8       0.1       -0.6      0.7       .832
        **Stage at diagnosis**                                                                                                                                                                            
        HIV infection stage 3(AIDS)                          19,669                   69.2       20,250        70.4       20,732        70.8       20,973        70.3       0.5       -0.1      1.1       .101
        Not known to be HIV infection stage 3                56,297                   66.2       59,408        67.6       62,780        68.5       65,235        68.4       1.1       0.8       1.5       \<.001
        **Transmission Category^c^**                                                                                                                                                                      
        Male-to-male sexual contact                          45,019                   69.0       48,073        70.2       51,704        71.1       54,684        71.1       1.0       0.6       1.4       \<.001
        Injection drug use                                   12,834                   59.5       13,004        61.3       12,738        61.0       12,319        59.9       0.2       -0.6      1.0       .650
        Male-to-male sexual contact and injection drug use   6,359                    71.8       6,407         73.8       6,462         74.8       6,332         73.5       0.8       -0.3      1.9       .135
        Heterosexual contact**^d^**                          11,570                   66.1       11,987        67.0       12,413        67.5       12,680        67.4       0.7       -0.1      1.5       .108
        Other**^e^**                                         184                      63.2       187           63.2       195           64.5       193           62.2       -0.3      -6.4      6.3       .930
  **Black Female**                                                                                                                                                                                        
        **Age group at diagnosis**                                                                                                                                                                        
        13-24                                                1,477                    69.8       1,412         72.3       1,341         71.7       1,266         74.3       1.8       -0.6      4.3       .133
        25-34                                                6,182                    66.8       6,012         67.6       5,845         67.8       5,804         68.7       0.9       -0.2      2.0       .127
        35-44                                                11,461                   68.2       11,460        69.3       11,365        69.9       11,319        70.3       1.0       0.2       1.8       .020
        45-54                                                13,997                   73.3       14,297        73.5       14,582        73.4       14,736        73.0       -0.1      -0.8      0.6       .774
        55+                                                  8,132                    72.8       9,251         73.4       10,318        73.5       11,451        73.2       0.2       -0.7      1.0       .738
        **Stage at diagnosis**                                                                                                                                                                            
        HIV infection stage 3(AIDS)                          9,540                    73.4       9,758         74.0       9,948         74.3       10,141        74.1       0.3       -0.5      1.2       .459
        Not known to be HIV infection stage 3                31,709                   69.8       32,674        70.6       33,503        70.9       34,435        71.1       0.6       0.1       1.1       .012
        **Transmission Category^c^**                                                                                                                                                                      
        Injection drug use                                   10,264                   69.1       10,221        69.9       10,102        69.9       9,931         69.3       0.1       -0.8      1.0       .832
        Heterosexual contact**^d^**                          30,771                   71.1       31,982        71.8       33,119        72.1       34,414        72.5       0.7       0.2       1.2       .008
        Other**^e^**                                         214                      71.8       230           75.3       230           74.0       231           73.0       0.3       -5.4      6.3       .918
  **Hispanic/Latino Male**                                                                                                                                                                                
        **Age group at diagnosis**                                                                                                                                                                        
        13-24                                                2,183                    70.8       2,422         73.6       2,571         77.7       2,676         77.8       3.3       1.5       5.2       \<.001
        25-34                                                10,254                   67.6       10,952        68.9       11,973        71.5       12,631        72.5       2.5       1.7       3.3       \<.001
        35-44                                                17,365                   67.8       17,085        67.9       17,026        68.7       16,973        68.6       0.5       -0.2      1.1       .167
        45-54                                                19,947                   69.0       21,062        69.5       22,025        69.7       22,554        69.1       0.0       -0.6      0.6       .879
        55+                                                  9,694                    65.0       10,874        65.0       12,219        65.5       13,500        65.0       0.1       -0.8      0.9       .892
        **Stage at diagnosis**                                                                                                                                                                            
        HIV infection stage 3(AIDS)                          16,836                   64.6       17,505        65.2       18,097        65.6       18,544        65.5       0.5       -0.2      1.2       .142
        Not known to be HIV infection stage 3                42,607                   69.2       44,890        69.5       47,717        70.7       49,790        70.4       0.7       0.3       1.1       .001
        **Transmission Category^c^**                                                                                                                                                                      
        Male-to-male sexual contact                          42,691                   69.9       45,560        70.5       48,849        71.7       51,470        71.5       0.8       0.4       1.2       \<.001
        Injection drug use                                   7,210                    56.4       7,068         55.7       7,026         55.7       6,861         54.8       -0.9      -1.9      0.2       .106
        Male-to-male sexual contact and injection drug use   4,915                    73.1       5,004         74.0       4,999         73.8       4,975         73.3       0.0       -1.2      1.3       .971
        Heterosexual contact**^d^**                          4,495                    64.8       4,627         65.1       4,806         65.5       4,900         64.9       0.1       -1.2      1.4       .876
        Other**^e^**                                         133                      63.4       136           64.4       134           64.4       127           61.9       -0.7      -8.0      7.2       .863
  **Hispanic/Latino Female**                                                                                                                                                                              
        **Age group at diagnosis**                                                                                                                                                                        
        13-24                                                406                      70.2       381           70.4       372           74.3       348           73.4       1.9       -2.6      6.6       .417
        25-34                                                2,139                    69.4       2,065         70.2       1,978         70.2       1,923         70.0       0.3       -1.7      2.2       .791
        35-44                                                4,262                    71.9       4,228         72.5       4,177         73.3       3,993         72.4       0.4       -1.0      1.7       .611
        45-54                                                5,553                    75.5       5,640         75.5       5,771         76.0       5,759         75.5       0.1       -1.1      1.3       .875
        55+                                                  3,433                    74.5       3,804         74.2       4,242         74.6       4,689         73.6       -0.4      -1.7      1.0       .612
        **Stage at diagnosis**                                                                                                                                                                            
        HIV infection stage 3(AIDS)                          3,760                    72.3       3,799         72.2       3,882         72.7       3,932         72.1       0.0       -1.4      1.4       .980
        Not known to be HIV infection stage 3                12,033                   73.6       12,319        74.0       12,658        74.7       12,780        74.0       0.2       -0.5      1.0       .549
        **Transmission Category^c^**                                                                                                                                                                      
        Injection drug use                                   4,256                    71.8       4,211         71.8       4,170         71.7       4,107         71.1       -0.3      -1.6      1.1       .689
        Heterosexual contact**^d^**                          11,440                   73.9       11,810        74.2       12,274        75.1       12,511        74.4       0.3       -0.5      1.1       .445
        Other**^e^**                                         97                       70.3       97            71.6       95            70.3       94            68.3       -1.0      -9.5      8.2       .819
  **White Male**                                                                                                                                                                                          
        **Age group at diagnosis**                                                                                                                                                                        
        13-24                                                1,181                    74.3       1,215         75.5       1,246         76.4       1,292         77.6       1.5       -1.0      4.0       .258
        25-34                                                7,593                    74.6       8,077         76.3       8,378         76.9       8,602         76.4       0.8       -0.2      1.8       .117
        35-44                                                18,741                   75.1       17,634        75.8       16,721        76.6       15,606        75.7       0.4       -0.3      1.1       .267
        45-54                                                36,888                   76.3       37,190        76.7       37,270        77.7       36,283        76.8       0.4       -0.1      0.8       .127
        55+                                                  23,565                   74.2       26,448        75.0       29,709        76.7       32,516        76.1       0.9       0.4       1.5       \<.001
        **Stage at diagnosis**                                                                                                                                                                            
        HIV infection stage 3(AIDS)                          20,210                   74.4       20,660        74.9       21,108        75.9       21,276        75.6       0.6       0.0       1.2       .053
        Not known to be HIV infection stage 3                67,758                   75.6       69,904        76.3       72,216        77.5       73,023        76.6       0.6       0.2       0.9       .001
        **Transmission Category^c^**                                                                                                                                                                      
        Male-to-male sexual contact                          73,065                   76.0       75,358        76.6       77,922        77.8       78,872        76.9       0.5       0.1       0.8       .004
        Injection drug use                                   3,936                    62.2       4,012         63.6       4,036         64.5       4,004         63.9       1.0       -0.4      2.4       .171
        Male-to-male sexual contact and injection drug use   8,210                    77.4       8,318         78.3       8,428         79.7       8,406         79.6       1.0       0.0       2.0       .041
        Heterosexual contact**^d^**                          2,346                    71.6       2,483         73.6       2,557         73.6       2,633         74.2       1.1       -0.7      2.9       .234
        Other**^e^**                                         410                      73.9       392           72.7       381           73.3       384           74.0       0.1       -4.2      4.6       .968
  **White Female**                                                                                                                                                                                        
        **Age group at diagnosis**                                                                                                                                                                        
        13-24                                                259                      69.4       243           69.2       204           68.7       182           65.9       -1.5      -7.2      4.5       .610
        25-34                                                1,365                    67.6       1,340         68.3       1,294         68.1       1,275         68.8       0.5       -1.9      2.9       .701
        35-44                                                2,681                    68.1       2,639         69.5       2,521         69.2       2,448         69.2       0.4       -1.3      2.2       .643
        45-54                                                3,690                    70.5       3,790         71.2       3,843         71.0       3,864         71.5       0.4       -1.0      1.8       .607
        55+                                                  2,244                    71.5       2,500         71.7       2,773         71.7       3,094         71.7       0.1       -1.6      1.8       .936
        **Stage at diagnosis**                                                                                                                                                                            
        HIV infection stage 3(AIDS)                          2,221                    71.5       2,313         73.1       2,336         72.5       2,369         73.0       0.5       -1.3      2.4       .573
        Not known to be HIV infection stage 3                8,018                    69.2       8,199         69.7       8,299         69.7       8,494         69.9       0.3       -0.6      1.3       .512
        **Transmission Category^c^**                                                                                                                                                                      
        Injection drug use                                   3,306                    65.9       3,332         66.6       3,342         66.9       3,337         66.9       0.5       -1.1      2.0       .560
        Heterosexual contact**^d^**                          6,789                    71.7       7,040         72.5       7,155         72.1       7,384         72.4       0.2       -0.8      1.3       .653
        Other**^e^**                                         145                      66.5       139           65.8       138           66.8       142           68.9       1.2       -6.0      8.9       .748
  **Total**                                                  **312,438**              **70.9**   **324,209**   **71.7**   **336,629**   **72.5**   **344,835**   **72.2**   **0.6**   **0.4**   **0.8**   **\<.001**

Abbreviations: HIV= Human Immunodeficiency Virus, EAPC=Estimated Annual Percent Change. Note: The denominator for each characteristic for each year are not presented. ^a^Jurisdictions include California, District of Columbia, Hawaii, Iowa, Illinois, Indiana, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, North Dakota, South Carolina, Texas, Utah, and West Virginia. ^b^Defined as one or more CD4+ T-lymphocyte or viral load test performed during the outcome year. ^c^Data statistically adjusted to account for missing transmission categories. ^d^Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. ^e^Includes hemophilia, blood transfusion, perinatal exposure and risk factor not reported or not identified.

###### 

Viral suppression among persons aged ≥13 years living with HIV, 17 US jurisdictions^a^, 2012-2015

  **Characteristic**                                         **Viral Suppression**                                                                                                                       
  ---------------------------------------------------------- ----------------------- ---------- ------------- ---------- ------------- ---------- ------------- ---------- --------- --------- --------- ------------
  **Sex**                                                                                                                                                                                                
        Male                                                 184,330                 54.3       199,908       57.2       214,601       59.6       221,923       59.8       3.3       3.1       3.5       \<.001
        Female                                               50,921                  50.5       54,913        53.6       58,458        56.0       60,886        57.1       4.2       3.8       4.6       \<.001
  **Race/Ethnicity**                                                                                                                                                                                     
        Black/Afican American                                80,058                  46.6       87,808        49.9       94,951        52.3       99,078        52.9       4.3       4         4.6       \<.001
        Hispanic/Latino                                      58,732                  53.8       63,416        56.0       68,760        58.6       71,787        59.0       3.2       2.9       3.6       \<.001
        White                                                80,078                  60.9       85,921        64.1       90,356        66.4       92,223        66.4       3         2.7       3.3       \<.001
        Other                                                16,383                  59.3       17,676        62.3       18,992        64.8       19,721        65.7       3.5       2.8       4.2       \<.001
  **Age group at diagnosis**                                                                                                                                                                             
        13-24                                                6,201                   39.8       7,200         45.2       7,911         49.9       8,246         52.8       9.8       8.6       10.9      \<.001
        25-34                                                28,504                  45.8       32,115        50.1       35,666        53.3       38,058        54.5       5.9       5.4       6.4       \<.001
        35-44                                                56,423                  51.6       57,282        54.3       58,184        56.8       57,243        57.1       3.5       3.1       3.9       \<.001
        45-54                                                88,692                  56.5       94,059        59.0       98,182        61.0       98,479        61.0       2.7       2.4       3         \<.001
        55+                                                  55,431                  57.7       64,165        59.9       73,116        61.8       80,783        61.8       2.3       2         2.7       \<.001
  **Stage at diagnosis**                                                                                                                                                                                 
        HIV infection stage 3(AIDS)                          61,281                  56.1       65,045        58.4       68,374        60.4       69,991        60.6       2.7       2.3       3         \<.001
        Not known to be HIV infection stage 3                173,970                 52.5       189,776       55.7       204,685       58.3       212,818       58.7       3.8       3.6       4         \<.001
  **Transmission Category^c^**                                                                                                                                                                           
        Male-to-male sexual contact                          135,257                 56.9       148,554       60.0       160,922       62.4       168,400       62.6       3.2       3         3.5       \<.001
        Injection drug use                                   31,578                  44.9       32,747        47.2       33,706        49.1       33,182        48.8       2.9       2.4       3.4       \<.001
        Male-to-male sexual contact and injection drug use   15,331                  53.7       16,017        56.5       16,769        59.3       16,652        59.0       3.3       2.6       4.1       \<.001
        Heterosexual contact**^d^**                          52,111                  51.1       56,492        54.0       60,613        56.3       63,499        57.3       3.9       3.5       4.2       \<.001
        Other**^e^**                                         974                     52.3       1,011         54.7       1,050         57.2       1,076         58.2       3.7       0.9       6.6       .009
  **Total**                                                  **235,251**             **53.4**   **254,821**   **56.4**   **273,059**   **58.8**   **282,809**   **59.2**   **3.5**   **3.3**   **3.7**   **\<.001**

Abbreviations: HIV= Human Immunodeficiency Virus, EAPC=Estimated Annual Percent Change. Note: The denominator for each characteristic for each year are not presented. ^a^Jurisdictions include California, District of Columbia, Hawaii, Iowa, Illinois, Indiana, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, North Dakota, South Carolina, Texas, Utah, and West Virginia. ^b^Defined as a viral load result of \<200 copies/mL or, if the quantitative value was missing, a test interpretation value of "undetected", at the time of the most recent viral load test during the outcome year. ^c^Data statistically adjusted to account for missing transmission categories. ^d^Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. ^e^Includes hemophilia, blood transfusion, perinatal exposure and risk factor not reported or not identified.

###### 

Viral suppression among persons aged ≥13 years living with HIV in 17 US jurisdictions by race, sex and selected characteristics, 2012-2015

  **Characteristic**                                         **Viral Suppression**                                                                                                                       
  ---------------------------------------------------------- ----------------------- ---------- ------------- ---------- ------------- ---------- ------------- ---------- --------- --------- --------- ------------
  **Black Male**                                                                                                                                                                                         
        **Age group at diagnosis**                                                                                                                                                                       
        13-24                                                2,513                   36.6       2,967         41.5       3,348         46.4       3,436         48.3       9.8       8.0       11.5      \<.001
        25-34                                                7,340                   40.3       8,697         44.9       10,253        48.3       11,560        49.7       7.0       6.0       8.0       \<.001
        35-44                                                11,105                  45.2       11,413        48.6       11,852        51.5       11,666        51.4       4.5       3.7       5.4       \<.001
        45-54                                                18,904                  48.8       20,028        51.9       20,868        53.9       20,553        53.7       3.2       2.6       3.9       \<.001
        55+                                                  12,388                  49.3       14,368        51.3       16,204        52.6       17,856        52.8       2.3       1.5       3.0       \<.001
        **Stage at diagnosis**                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          14,476                  51.0       15,418        53.6       16,244        55.4       16,603        55.7       3.0       2.3       3.7       \<.001
        Not known to be HIV infection stage 3                37,774                  44.4       42,055        47.9       46,281        50.5       48,468        50.8       4.6       4.1       5.0       \<.001
        **Transmission Category^c^**                                                                                                                                                                     
        Male-to-male sexual contact                          30,899                  47.3       34,892        50.9       38,904        53.5       41,682        54.2       4.5       4.1       5.0       \<.001
        Injection drug use                                   8,850                   41.0       9,267         43.7       9,451         45.2       9,040         44.0       2.5       1.5       3.4       \<.001
        Male-to-male sexual contact and injection drug use   4,202                   47.4       4,394         50.6       4,651         53.8       4,513         52.4       3.6       2.3       5.0       \<.001
        Heterosexual contact**^d^**                          8,182                   46.8       8,800         49.2       9,379         51.0       9,699         51.6       3.3       2.4       4.3       \<.001
        Other**^e^**                                         117                     40.2       120           40.6       140           46.3       137           44.3       4.3       -3.5      12.7      .288
  **Black Female**                                                                                                                                                                                       
        **Age group at diagnosis**                                                                                                                                                                       
        13-24                                                683                     32.3       741           37.9       758           40.6       778           45.7       11.7      8.1       15.4      \<.001
        25-34                                                3,544                   38.3       3,727         41.9       3,780         43.8       3,901         46.2       6.2       4.7       7.8       \<.001
        35-44                                                7,537                   44.9       7,909         47.8       8,228         50.6       8,352         51.8       5.0       4.0       6.0       \<.001
        45-54                                                9,887                   51.7       10,560        54.3       11,190        56.3       11,487        56.9       3.2       2.4       4.1       \<.001
        55+                                                  6,157                   55.1       7,398         58.7       8,470         60.3       9,489         60.6       3.0       2.0       4.1       \<.001
        **Stage at diagnosis**                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          6,984                   53.7       7,471         56.7       7,823         58.4       8,140         59.5       3.4       2.4       4.4       \<.001
        Not known to be HIV infection stage 3                20,824                  45.8       22,864        49.4       24,603        52.0       25,867        53.4       5.2       4.6       5.8       \<.001
        **Transmission Category^c^**                                                                                                                                                                     
        Injection drug use                                   6,693                   45.1       7,062         48.3       7,318         50.6       7,323         51.1       4.3       3.2       5.4       \<.001
        Heterosexual contact**^d^**                          20,969                  48.4       23,108        51.9       24,930        54.3       26,503        55.9       4.8       4.2       5.4       \<.001
        Other**^e^**                                         146                     49.1       166           54.2       178           57.3       182           57.4       5.2       -1.7      12.6      .140
  **Hispanic/Latino Male**                                                                                                                                                                               
        **Age group at diagnosis**                                                                                                                                                                       
        13-24                                                1,389                   45.1       1,677         51.0       1,904         57.5       2,044         59.4       9.7       7.4       12.0      .001
        25-34                                                7,437                   49.0       8,360         52.6       9,452         56.4       10,111        58.0       5.8       4.9       6.8       \<.001
        35-44                                                13,552                  52.9       13,819        54.9       14,225        57.4       14,231        57.5       3.0       2.2       3.7       \<.001
        45-54                                                16,193                  56.1       17,525        57.8       18,893        59.8       19,501        59.8       2.2       1.6       2.9       \<.001
        55+                                                  8,258                   55.4       9,455         56.5       10,909        58.5       12,037        57.9       1.6       0.8       2.5       \<.001
        **Stage at diagnosis**                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          13,921                  53.4       14,727        54.9       15,701        57.0       16,111        56.9       2.3       1.6       3.0       \<.001
        Not known to be HIV infection stage 3                32,908                  53.4       36,109        55.9       39,682        58.8       41,813        59.1       3.5       3.1       4.0       \<.001
        **Transmission Category^c^**                                                                                                                                                                     
        Male-to-male sexual contact                          34,225                  56.1       37,902        58.6       41,716        61.2       44,306        61.6       3.2       2.8       3.7       \<.001
        Injection drug use                                   5,439                   42.6       5,462         43.1       5,662         44.9       5,526         44.1       1.5       0.3       2.7       .012
        Male-to-male sexual contact and injection drug use   3,520                   52.4       3,667         54.2       3,854         56.9       3,835         56.5       2.8       1.3       4.2       \<.001
        Heterosexual contact**^d^**                          3,533                   51.0       3,691         51.9       4,033         54.9       4,137         54.8       2.8       1.3       4.2       \<.001
        Other**^e^**                                         112                     53.6       115           54.4       119           57.3       120           58.3       3.1       -4.9      11.9      .460
  **Hispanic/Latino Female**                                                                                                                                                                             
        **Age group at diagnosis**                                                                                                                                                                       
        13-24                                                246                     42.6       239           44.2       243           48.5       234           49.4       5.5       -0.3      11.7      .061
        25-34                                                1,409                   45.7       1,449         49.3       1,452         51.5       1,450         52.8       4.9       2.5       7.3       \<.001
        35-44                                                3,117                   52.6       3,153         54.0       3,248         57.0       3,197         58.0       3.5       1.9       5.2       \<.001
        45-54                                                4,282                   58.2       4,454         59.7       4,717         62.1       4,828         63.3       3.0       1.7       4.3       \<.001
        55+                                                  2,849                   61.9       3,285         64.1       3,717         65.4       4,154         65.2       1.7       0.2       3.2       .028
        **Stage at diagnosis**                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          2,990                   57.5       3,121         59.3       3,298         61.8       3,410         62.5       2.9       1.4       4.6       \<.001
        Not known to be HIV infection stage 3                8,913                   54.5       9,459         56.8       10,079        59.4       10,453        60.5       3.6       2.7       4.5       \<.001
        **Transmission Category^c^**                                                                                                                                                                     
        Injection drug use                                   3,037                   51.2       3,099         52.9       3,194         54.9       3,260         56.5       3.4       1.8       5.0       \<.001
        Heterosexual contact**^d^**                          8,792                   56.8       9,406         59.1       10,105        61.8       10,525        62.6       3.4       2.5       4.3       \<.001
        Other**^e^**                                         74                      53.8       75            55.2       78            57.6       78            56.9       2.1       -7.6      12.9      .679
  **White Male**                                                                                                                                                                                         
        **Age group at diagnosis**                                                                                                                                                                       
        13-24                                                803                     50.5       931           57.8       966           59.3       1,060         63.7       7.3       4.3       10.4      \<.001
        25-34                                                5,580                   54.9       6,420         60.6       6,911         63.4       7,152         63.6       4.8       3.7       6.0       \<.001
        35-44                                                14,844                  59.5       14,568        62.6       14,139        64.8       13,338        64.7       2.9       2.2       3.7       \<.001
        45-54                                                30,648                  63.4       32,129        66.2       32,669        68.1       32,065        67.9       2.4       1.9       2.9       \<.001
        55+                                                  20,434                  64.3       23,543        66.8       26,875        69.4       29,606        69.3       2.5       2.0       3.1       \<.001
        **Stage at diagnosis**                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          17,032                  62.7       18,019        65.3       18,688        67.2       18,950        67.3       2.4       1.7       3.1       \<.001
        Not known to be HIV infection stage 3                55,277                  61.6       59,572        65.0       62,872        67.4       64,271        67.4       3.0       2.7       3.4       \<.001
        **Transmission Category^c^**                                                                                                                                                                     
        Male-to-male sexual contact                          60,780                  63.3       65,462        66.5       68,995        68.9       70,553        68.8       2.8       2.5       3.2       \<.001
        Injection drug use                                   3,024                   47.8       3,171         50.3       3,252         52.0       3,210         51.3       2.5       0.9       4.1       .002
        Male-to-male sexual contact and injection drug use   6,244                   58.9       6,541         61.6       6,810         64.4       6,877         65.1       3.5       2.4       4.6       \<.001
        Heterosexual contact**^d^**                          1,932                   58.9       2,083         61.7       2,172         62.5       2,238         63.1       2.2       0.2       4.1       .028
        Other**^e^**                                         329                     59.4       334           61.9       332           63.7       343           66.1       3.6       -1.3      8.6       .151
  **White Female**                                                                                                                                                                                       
        **Age group at diagnosis**                                                                                                                                                                       
        13-24                                                147                     39.4       148           42.2       132           44.4       127           46.0       5.3       -2.2      13.5      .172
        25-34                                                907                     44.9       921           47.0       965           50.8       926           49.9       4.0       1.1       7.1       .007
        35-44                                                1,925                   48.9       1,978         52.1       1,952         53.6       1,907         53.9       3.2       1.2       5.3       .002
        45-54                                                2,926                   55.9       3,116         58.5       3,265         60.3       3,274         60.6       2.7       1.1       4.3       \<.001
        55+                                                  1,864                   59.4       2,167         62.1       2,482         64.1       2,768         64.1       2.5       0.7       4.4       .007
        **Stage at diagnosis**                                                                                                                                                                           
        HIV infection stage 3(AIDS)                          1,786                   57.5       1,914         60.5       2,017         62.6       2,047         63.1       3.1       1.1       5.2       .003
        Not known to be HIV infection stage 3                5,983                   51.6       6,416         54.6       6,779         56.9       6,955         57.3       3.6       2.4       4.7       \<.001
        **Transmission Category^c^**                                                                                                                                                                     
        Injection drug use                                   2,359                   47.1       2,518         50.4       2,625         52.5       2,620         52.5       3.7       1.9       5.6       \<.001
        Heterosexual contact**^d^**                          5,294                   55.9       5,689         58.6       6,055         61.0       6,255         61.4       3.2       2.0       4.4       \<.001
        Other**^e^**                                         116                     53.4       123           58.0       116           56.2       127           61.6       4.1       -3.9      12.7      .327
  **Total**                                                  **235,251**             **53.4**   **254,821**   **56.4**   **273,059**   **58.8**   **282,809**   **59.2**   **3.5**   **3.3**   **3.7**   **\<.001**

Abbreviations: HIV= Human Immunodeficiency Virus, EAPC=Estimated Annual Percent Change. Note: The denominator for each characteristic for each year are not presented. ^a^Jurisdictions include California, District of Columbia, Hawaii, Iowa, Illinois, Indiana, Louisiana, Maryland, Michigan, Missouri, New Hampshire, New York, North Dakota, South Carolina, Texas, Utah, and West Virginia. ^b^Defined as a viral load result of \<200 copies/mL or, if the quantitative value was missing, a test interpretation value of "undetected", at the time of the most recent viral load test during the outcome year. ^c^Data statistically adjusted to account for missing transmission categories. ^d^Heterosexual contact with a person known to have, or to be at high risk for, HIV infection. ^e^Includes hemophilia, blood transfusion, perinatal exposure and risk factor not reported or not identified.
